Cargando…
Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
BACKGROUND: Von Willebrand factor (VWF) elevation correlates with the left atrial blood stasis in nonvalvular atrial fibrillation (NVAF). However, the long-term impact of elevated VWF in patients with NVAF is not well established. METHODS: To assess the impact of VWF and a disintegrin and metallopro...
Autores principales: | Wysokinski, Waldemar E., Melduni, Rowlens M., Ammash, Naser M., Vlazny, Danielle T., Konik, Ewa, Saadiq, Rayya A., Gosk-Bierska, Izabela, Slusser, Joshua, Grill, Diane, McBane, Robert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984998/ https://www.ncbi.nlm.nih.gov/pubmed/33778448 http://dx.doi.org/10.1016/j.cjco.2020.10.018 |
Ejemplares similares
-
P1645: IMPACT OF VON WILLEBRAND FACTOR AND ADAMTS13 ON CARDIOVASCULAR COMPLICATIONS AND BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND NORMAL SINUS RHYTHM CONTROLS: 10 YEARS FOLLOW UP.
por: Wysokinski, Waldemar, et al.
Publicado: (2023) -
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015) -
ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020) -
The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022) -
ADAMTS‐13 and von Willebrand factor: a dynamic duo
por: South, K., et al.
Publicado: (2017)